Skip to main content

Premier Biomedical, Inc. (BIEI)

OTCMKTS: BIEI · Delayed Price · USD
0.0032 0.0000 (0.00%)
Sep 17, 2021 3:53 PM EDT - Market closed
Market Cap3.20M
Revenue (ttm)14,281
Net Income (ttm)-374,470
Shares Out52.40M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume928,932
Open0.0030
Previous Close0.0032
Day's Range0.0019 - 0.0033
52-Week Range0.0007 - 0.0048
Beta-5.22
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About BIEI

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca...

IndustryBiotechnology
Founded2010
CEOWilliam Hartman
CountryUnited States
Stock ExchangeOTCMKTS
Ticker SymbolBIEI
Full Company Profile

Financial Performance

In 2019, BIEI's revenue was $14,281, a decrease of -64.11% compared to the previous year's $39,795. Losses were -$374,470, -6.12% less than in 2018.

Financial Statements

News

There is no news available yet.